Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the ...

Ad Hoc Announcement Pursuant to Art.?53 LR Geneva, Switzerland, July 8, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing ...

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the release of its latest CEO Corner segment, featuring Chief Executive Officer Thomas Equels discussing the Company's ...

The mid-stage disappointment in Alzheimer’s disease delivers another blow to Neuphoria Therapeutics, which in November last year was forced to launch a strategic business review after a Phase 3 trial ...

Unlike traditional proteins, its short structure allows it to act as an epigenetic modulator, potentially influencing gene ...

Cork amateur David Howard will compete at the Open Championship next month after he was one of five golfers to secure a spot ...

Even after the introduction of ETI for cystic fibrosis, habit continues to have a key role in adherence to inhaled medicines in patients with CF.

Alzheimer’s disease is one of the biggest health threats of our time. According to the Alzheimer’s Association, an estimated 7.4 million Americans 65 and older are currently living with Alzheimer’s ...

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 30, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing ...

If you have schizophrenia, two specific neurotransmitters, serotonin and dopamine, may be out of balance. Your doctor may prescribe serotonin-dopamine activity modulators, or SDAMs. These drugs – also ...

The controversial Enhanced Games kick off this weekend in Las Vegas but the sporting event won't be a free-for-all when it comes to boosting performance. Created by Australian businessman Aron DSouza, ...